HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lufeng Zheng Selected Research

splenotritin (TP3)

11/2021Discovery of a Dual Tubulin and Poly(ADP-Ribose) Polymerase-1 Inhibitor by Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, and Biological Evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lufeng Zheng Research Topics

Disease

26Breast Neoplasms (Breast Cancer)
01/2023 - 10/2014
21Neoplasms (Cancer)
05/2024 - 01/2015
12Neoplasm Metastasis (Metastasis)
02/2022 - 01/2015
4Carcinogenesis
04/2024 - 04/2017
3Stomach Neoplasms (Stomach Cancer)
12/2023 - 08/2021
2Inflammation (Inflammations)
10/2019 - 10/2017
1Prostatic Neoplasms (Prostate Cancer)
04/2024
1Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021
1Iron Metabolism Disorders
01/2021
1Immune System Diseases (Immune Disorders)
01/2021
1Ulcerative Colitis
10/2019
1Helicobacter Infections
01/2019
1Infections
10/2017
1Melanoma (Melanoma, Malignant)
01/2015

Drug/Important Bio-Agent (IBA)

15Competitive Endogenous RNAIBA
01/2020 - 02/2015
123' Untranslated Regions (3' UTR)IBA
01/2020 - 10/2014
8MicroRNAs (MicroRNA)IBA
01/2023 - 02/2015
7Proteins (Proteins, Gene)FDA Link
04/2024 - 10/2015
4TamoxifenFDA LinkGeneric
01/2019 - 05/2016
3RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2022 - 01/2018
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2021 - 10/2014
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020 - 01/2018
3Messenger RNA (mRNA)IBA
01/2018 - 04/2016
2Biomarkers (Surrogate Marker)IBA
05/2024 - 12/2023
2TubulinIBA
12/2023 - 11/2021
2EnzymesIBA
12/2023 - 12/2022
2RNA (Ribonucleic Acid)IBA
01/2023 - 11/2020
2tanshinoneIBA
02/2022 - 05/2019
2Estrogen ReceptorsIBA
01/2018 - 05/2016
1Sulfonic AcidsIBA
05/2024
1Palmitoyl Coenzyme A (Palmitoyl CoA)IBA
05/2024
1diphosphoric acid (pyrophosphoric acid)IBA
05/2024
1anlotinibIBA
05/2024
1Inositol PhosphatesIBA
05/2024
1CholesterolIBA
05/2024
1ErbB Receptors (EGF Receptor)IBA
04/2024
1Neuropilin-1IBA
12/2023
1Immune Checkpoint ProteinsIBA
12/2023
1ImmunosorbentsIBA
12/2023
1Circular RNAIBA
12/2023
1LuciferasesIBA
01/2023
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
12/2022
1phenazineFDA Link
06/2022
1Glutathione (Reduced Glutathione)IBA
02/2022
1Lipid PeroxidesIBA
02/2022
1erastinIBA
02/2022
1Sorafenib (BAY 43-9006)FDA Link
02/2022
1Sulfasalazine (Azulfidine)FDA LinkGeneric
02/2022
1Ligases (Synthetase)IBA
01/2022
1UbiquitinIBA
01/2022
1Proteolysis Targeting ChimeraIBA
01/2022
1splenotritin (TP3)IBA
11/2021
1Poly (ADP-Ribose) Polymerase-1IBA
11/2021
1Interleukin-10 (Interleukin 10)IBA
08/2021
1Interleukin-6 (Interleukin 6)IBA
08/2021
1HET0016IBA
01/2021
1Small Untranslated RNAIBA
01/2021
1IronIBA
01/2021
1Transcription Factors (Transcription Factor)IBA
09/2020
1limoninIBA
10/2019
1TriterpenesIBA
10/2019
1AntigensIBA
01/2019
1Actins (F Actin)IBA
01/2018
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
01/2018
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
01/2018
1Cyclin-Dependent Kinase 3IBA
01/2018
1rho GTPase-activating proteinIBA
10/2017
1ChemokinesIBA
10/2017
1VaccinesIBA
10/2017
1Estrogens (Estrogen)FDA Link
05/2016
1Long Noncoding RNAIBA
03/2016
1Cadherins (E-Cadherin)IBA
01/2016
1Untranslated RNA (Noncoding RNA)IBA
10/2015
1Chemokine ReceptorsIBA
10/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2015
1Indicators and Reagents (Reagents)IBA
01/2015

Therapy/Procedure

7Therapeutics
05/2024 - 05/2016
2Drug Therapy (Chemotherapy)
03/2019 - 01/2019
1Precision Medicine
11/2021
1Immunotherapy
01/2021